Corpus Intelligence IC Memo — WEBSTER COUNTY COMMUNITY HOSPITAL 2026-04-27 00:12 UTC
IC Memo — WEBSTER COUNTY COMMUNITY HOSPITAL
Investment Committee Memorandum | NE | 13 beds | Grade D | EBITDA uplift $441K
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 281316

WEBSTER COUNTY COMMUNITY HOSPITAL

LOCATIONWEBSTER, NE·BEDS13·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

WEBSTER COUNTY COMMUNITY HOSPITAL is a 13-bed rural/critical access in WEBSTER, NE with $5.8M in net patient revenue and a -14.0% operating margin. The hospital serves a payer mix of 54.3% Medicare, 1.2% Medicaid, and 44.5% commercial.

Thesis: Turnaround. Our ML models identify $441K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.0% to -6.5% (+755bps).

Net Revenue HCRIS$5.8M
Current EBITDA COMPUTED$-817K
Operating Margin COMPUTED-14.0%
Occupancy HCRIS3.5%
Revenue / Bed COMPUTED$449K
Net-to-Gross HCRIS121.3%
Distress Probability ML67.2%

2. Market Context & Competitive Position

98
NE Hospitals
-6.3%
State Median Margin
67
Comparable Hospitals

NE has 98 Medicare-certified hospitals with a median operating margin of -6.3%. The target's margin of -14.0% places it below the state median. Among 67 size-comparable peers (6-26 beds), the median margin is -5.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-26), prioritizing same-state peers. 67 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WEBSTER COUNTY COMMUNITY HOSPI (Target)NE13$5.8M-14.0%
NEBRASKA ORTHOPAEDIC HOSPITAL NE24$112.1M22.5%
BEATRICE COMMUNITY HOSPITALNE25$84.6M-1.2%
LINCOLN SURGICAL HOSPITALNE20$80.9M18.8%
MIDWEST SURGICAL HOSPITALNE19$70.1M36.2%
PHELPS MEMORIAL HEALTH CENTERNE25$69.0M8.2%
SIDNEY REGIONAL MEDICAL CENTERNE19$68.0M0.8%
COMMUNITY HOSPITAL ASSOCOCIATINE25$56.0M-7.4%
YORK GENERAL HOSPITAL INCNE25$52.3M-1.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $441K (755bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$123K+210bp18mo
Denial Rate Reduction12.0%6.5%$121K+207bp12mo
Cost to Collect4.5%2.5%$117K+200bp12mo
A/R Days Reduction5200.0%3800.0%$71K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+16bp6mo

5. EBITDA Bridge

Net Collection Rate
$123K
Denial Rate Reduction
$121K
Cost to Collect
$117K
A/R Days Reduction
$71K
Clean Claim Rate
$10K
Total EBITDA Uplift$441K
Current EBITDA$-817K
+ RCM Uplift+$441K
Pro Forma EBITDA$-377K
Current Margin-14.0%
Pro Forma Margin-6.5%
WC Released (1x)$224K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.3M$-986K0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.3M$-1.5M0.00x-100.0%
Bull Case9.0x11.0x$-1.1M$-447K0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.1M$-822K0.00x-100.0%
Bear Case11.0x10.0x$-1.4M$-2.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.4M$-3.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 3.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 67.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 67 hospitals with 6-26 beds
  • Same-state prioritization (n=68)
  • Comp margins: P25=-12.5% / P50=-5.2% / P75=0.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.